Comparative Study on Recovery and Post-Operative Analgesic Efficacy from Fentanyl- Versus Dexmedetomidine-Based...

Area of Science:

• Anesthesiology
• Oncology
• Surgical Recovery

Background:

• Effective post-operative analgesia and rapid recovery are crucial for patients undergoing head and neck cancer surgery.
• This study investigates the comparative efficacy of fentanyl-based versus dexmedetomidine-based anesthesia in this patient group.

Purpose of the Study:

• To compare the recovery profiles and analgesic effectiveness of fentanyl-based anesthesia against dexmedetomidine-based anesthesia.
• To evaluate patient outcomes, including pain management and recovery speed, following head and neck cancer surgery.

Main Methods:

• A randomized controlled trial involving 120 patients undergoing head and neck cancer surgery.
• Patients were randomized into two groups: fentanyl-based anesthesia (Group F) or dexmedetomidine-based anesthesia (Group D).
• Recovery was assessed using the Modified Aldrete Score, and pain was measured via the Visual Analog Scale (VAS) at multiple time points post-surgery.

Main Results:

• Dexmedetomidine group (Group D) showed significantly faster recovery, with 85% achieving a Modified Aldrete Score of ≥9 within 30 minutes, versus 65% in the fentanyl group (Group F) (P < 0.05).
• Group D exhibited significantly lower post-operative VAS pain scores at all measured time points (P < 0.01).
• Total opioid consumption was reduced in Group D (50 mg morphine equivalents) compared to Group F (75 mg morphine equivalents) (P < 0.05), with comparable adverse effects.

Conclusions:

• Dexmedetomidine-based anesthesia offers superior post-operative analgesia and promotes faster recovery in patients undergoing head and neck cancer surgery.
• Dexmedetomidine may be a preferred anesthetic option for optimizing patient outcomes in this surgical population.